MX2011009597A - Deteccion mejorada de la expresion del gen. - Google Patents
Deteccion mejorada de la expresion del gen.Info
- Publication number
- MX2011009597A MX2011009597A MX2011009597A MX2011009597A MX2011009597A MX 2011009597 A MX2011009597 A MX 2011009597A MX 2011009597 A MX2011009597 A MX 2011009597A MX 2011009597 A MX2011009597 A MX 2011009597A MX 2011009597 A MX2011009597 A MX 2011009597A
- Authority
- MX
- Mexico
- Prior art keywords
- gene expression
- improved detection
- oligonucleotide
- primer
- detection
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title abstract 2
- 230000014509 gene expression Effects 0.000 title 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 3
- 239000000523 sample Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000011987 methylation Effects 0.000 abstract 1
- 238000007069 methylation reaction Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16093509P | 2009-03-17 | 2009-03-17 | |
| PCT/EP2010/001674 WO2010105815A2 (en) | 2009-03-17 | 2010-03-17 | Improved detection of gene expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011009597A true MX2011009597A (es) | 2012-05-29 |
Family
ID=42224406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011009597A MX2011009597A (es) | 2009-03-17 | 2010-03-17 | Deteccion mejorada de la expresion del gen. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120039993A1 (https=) |
| EP (1) | EP2408933A2 (https=) |
| JP (1) | JP2012520663A (https=) |
| KR (1) | KR20120002534A (https=) |
| CN (1) | CN102575284A (https=) |
| AU (1) | AU2010225125A1 (https=) |
| BR (1) | BRPI1009873A2 (https=) |
| CA (1) | CA2755734A1 (https=) |
| EA (1) | EA021100B1 (https=) |
| IL (1) | IL215182A0 (https=) |
| MX (1) | MX2011009597A (https=) |
| SG (1) | SG174877A1 (https=) |
| WO (1) | WO2010105815A2 (https=) |
| ZA (1) | ZA201107175B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2481813A1 (en) * | 2011-02-01 | 2012-08-01 | Centro di Riferimento Oncologico - Istituto Nazionale Tumori - Aviano | Markers of cutaneous melanoma and uses thereof |
| KR20130081515A (ko) | 2012-01-09 | 2013-07-17 | 삼성전자주식회사 | Ｌｅｄ 패키지용 기판 및 ｌｅｄ 패키지 제조방법 |
| US9096905B2 (en) * | 2012-02-23 | 2015-08-04 | Medical Diagnostic Laboratories, Llc | Detecting DNA methylation of BCL2, CDKN2A and NID2 genes to predict bladder cancer in humans |
| US11021752B2 (en) | 2013-03-15 | 2021-06-01 | Myriad Genetics, Inc. | Genes and gene signatures for diagnosis and treatment of melanoma |
| US20180187267A1 (en) * | 2017-01-05 | 2018-07-05 | Michael J. Powell | Method for conducting early detection of colon cancer and/or of colon cancer precursor cells and for monitoring colon cancer recurrence |
| EP3164508B1 (en) | 2014-07-02 | 2023-06-07 | Myriad myPath, LLC | Genes and gene signatures for diagnosis and treatment of melanoma |
| CN104611453B (zh) * | 2015-02-28 | 2016-08-24 | 基因科技（上海）有限公司 | 诊断基因甲基化的探针组及其应用 |
| WO2016208466A1 (ja) * | 2015-06-22 | 2016-12-29 | ウシオ電機株式会社 | 検出対象物質の検出方法 |
| DE102016005947B3 (de) | 2016-05-16 | 2017-06-08 | Dimo Dietrich | Verfahren zur Abschätzung der Prognose und zur Prädiktion des Ansprechens auf eine Immuntherapie von Patienten mit malignen Erkrankungen |
| US11685955B2 (en) | 2016-05-16 | 2023-06-27 | Dimo Dietrich | Method for predicting response of patients with malignant diseases to immunotherapy |
| CN109400697B (zh) * | 2017-08-17 | 2021-04-23 | 香雪生命科学技术（广东）有限公司 | 一种识别prame抗原短肽的tcr及其相关组合物 |
| US11441182B2 (en) * | 2018-08-08 | 2022-09-13 | Virginia Commonwealth University | Multiplexed and recyclable single-molecule sensors for quantitative analysis of nucleic-acid biomarkers |
| JP7216995B2 (ja) * | 2018-12-05 | 2023-02-02 | 学校法人関西医科大学 | 胸腺癌バイオマーカー及び胸腺腫瘍の予後予測マーカー |
| CN110387421A (zh) * | 2019-08-28 | 2019-10-29 | 深圳市新合生物医疗科技有限公司 | 用于肺癌检测的DNA甲基化qPCR试剂盒及使用方法 |
| RU2760573C1 (ru) * | 2021-01-20 | 2021-11-29 | Общество с ограниченной ответственностью "Эс Джи" | Набор олигонуклеотидных праймеров и флуоресцентно-меченых зондов для выявления эпигенетических маркеров рака шейки матки |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4437975A (en) | 1977-07-20 | 1984-03-20 | Mobil Oil Corporation | Manufacture of lube base stock oil |
| WO1989001050A1 (en) | 1987-07-31 | 1989-02-09 | The Board Of Trustees Of The Leland Stanford Junior University | Selective amplification of target polynucleotide sequences |
| US6723832B1 (en) | 1996-10-03 | 2004-04-20 | Ludwig Institute For Cancer Research | Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| US6417165B1 (en) | 1988-03-27 | 2002-07-09 | Ludwig Institute For Cancer Research | NY-ESO-1-peptide derivatives, and uses thereof |
| US5804381A (en) | 1996-10-03 | 1998-09-08 | Cornell Research Foundation | Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
| US6252052B1 (en) | 1996-10-03 | 2001-06-26 | Cornell Research Foundation, Inc | Antibodies which bind to NY-ESO-1 cancer associated proteins, and hybridomas which produce these antibodies |
| CA2005589C (en) | 1988-12-16 | 2001-02-06 | Akzo Nobel Nv | Self-sustained, sequence replication system |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| US5342774A (en) | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
| CA2138997C (en) | 1992-06-25 | 2003-06-03 | Jean-Paul Prieels | Vaccine composition containing adjuvants |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| EP1167379A3 (en) | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US5698396A (en) | 1995-06-07 | 1997-12-16 | Ludwig Institute For Cancer Research | Method for identifying auto-immunoreactive substances from a subject |
| US6017704A (en) | 1996-06-03 | 2000-01-25 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
| US6117635A (en) | 1996-07-16 | 2000-09-12 | Intergen Company | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| WO1998010087A1 (en) | 1996-09-06 | 1998-03-12 | Trustees Of The University Of Pennsylvania | Chimpanzee adenovirus vectors |
| US6251603B1 (en) | 1996-10-03 | 2001-06-26 | Ludwig Institute For Cancer Research | Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sample |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| DE19752759A1 (de) | 1997-11-28 | 1999-07-01 | Basf Coatings Ag | Triboelektrisch aufladbare Pulverlacke |
| CZ298364B6 (cs) | 1998-02-05 | 2007-09-05 | Smithkline Beecham Biologicals S. A. | Deriváty antigenu asociovaných s nádory z MAGE rodiny a sekvence nukleových kyselin kodující tyto deriváty, jejich použití pro prípravu fúzních proteinu a prostredku pro vakcinaci |
| US6140050A (en) | 1998-06-26 | 2000-10-31 | Ludwig Institute For Cancer Research | Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith |
| PT1104306E (pt) | 1998-08-10 | 2006-05-31 | Antigenics Inc | Composicoes de cpg e adjuvantes de saponina e seus metodos |
| US6800730B1 (en) | 1998-10-02 | 2004-10-05 | Ludwig Institute For Cancer Research | Isolated peptides which bind to MHC class II molecules, and uses thereof |
| PT1187629E (pt) | 1999-04-19 | 2005-02-28 | Glaxosmithkline Biolog Sa | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador |
| US6605711B1 (en) | 1999-11-15 | 2003-08-12 | Ludwig Institute For Cancer Research | NY-ESO-1 peptide derivatives, and uses thereof |
| US6689742B1 (en) | 2000-02-25 | 2004-02-10 | Chancellors, Masters And Scholars Of The University Of Oxford | NY-ESO-1 peptide derivatives, and uses thereof |
| US6756044B1 (en) | 2000-02-09 | 2004-06-29 | Genvec, Inc. | Antigenic complexes and methods |
| AU2002365366B2 (en) | 2001-11-21 | 2007-05-10 | The Trustees Of The University Of Pennsylvania | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| US20030134404A1 (en) | 2001-11-26 | 2003-07-17 | Lochrie Michael A. | Methods for producing stocks of recombinant AAV virions |
| DE60234386D1 (de) | 2002-02-04 | 2009-12-24 | Corixa Corp | Neue immuneffektor-verbindungen |
| WO2004067726A2 (en) | 2003-01-29 | 2004-08-12 | Keck Graduate Institute | Isothermal reactions for the amplification of oligonucleotides |
| US20050026183A1 (en) * | 2003-05-15 | 2005-02-03 | Jian-Bing Fan | Methods and compositions for diagnosing conditions associated with specific DNA methylation patterns |
| DE10329240A1 (de) * | 2003-06-24 | 2005-01-20 | Epigenomics Ag | Verfahren zur Analyse des Cytosin-Methylierungsstatus von Cancer-Testis-Antigenen für eine individualisierte Immuntherapie |
| GB0409940D0 (en) | 2004-05-04 | 2004-06-09 | Glaxosmithkline Biolog Sa | Vaccine |
| US20090005268A1 (en) * | 2005-07-18 | 2009-01-01 | Epigenomics Ag | Compositions and Methods for Cancer Diagnostics Comprising Pan-Cancer Markers |
| PT2114993E (pt) | 2007-01-15 | 2012-11-28 | Glaxosmithkline Biolog Sa | Vacina |
| ES2398492T3 (es) | 2007-01-15 | 2013-03-19 | Glaxosmithkline Biologicals Sa | Proteínas de fusión que comprenden los antígenos de rechazo tumoral NY-ESO-1 y LAGE-1 |
| US20120142546A1 (en) * | 2007-12-10 | 2012-06-07 | The Johns Hopkins University | Hypomethylated genes in cancer |
| WO2009108917A2 (en) * | 2008-02-29 | 2009-09-03 | Oncomethylome Sciences, S.A. | Markers for improved detection of breast cancer |
-
2010
- 2010-03-17 SG SG2011067386A patent/SG174877A1/en unknown
- 2010-03-17 AU AU2010225125A patent/AU2010225125A1/en not_active Abandoned
- 2010-03-17 JP JP2012500143A patent/JP2012520663A/ja active Pending
- 2010-03-17 WO PCT/EP2010/001674 patent/WO2010105815A2/en not_active Ceased
- 2010-03-17 EA EA201171131A patent/EA021100B1/ru not_active IP Right Cessation
- 2010-03-17 CN CN2010800214975A patent/CN102575284A/zh active Pending
- 2010-03-17 BR BRPI1009873A patent/BRPI1009873A2/pt not_active IP Right Cessation
- 2010-03-17 US US13/256,865 patent/US20120039993A1/en not_active Abandoned
- 2010-03-17 KR KR1020117024214A patent/KR20120002534A/ko not_active Withdrawn
- 2010-03-17 MX MX2011009597A patent/MX2011009597A/es not_active Application Discontinuation
- 2010-03-17 CA CA2755734A patent/CA2755734A1/en not_active Abandoned
- 2010-03-17 EP EP10711334A patent/EP2408933A2/en not_active Withdrawn
-
2011
- 2011-09-15 IL IL215182A patent/IL215182A0/en unknown
- 2011-09-30 ZA ZA2011/07175A patent/ZA201107175B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL215182A0 (en) | 2011-12-29 |
| KR20120002534A (ko) | 2012-01-05 |
| EA021100B1 (ru) | 2015-04-30 |
| WO2010105815A2 (en) | 2010-09-23 |
| ZA201107175B (en) | 2012-06-27 |
| AU2010225125A1 (en) | 2011-10-20 |
| BRPI1009873A2 (pt) | 2016-03-08 |
| US20120039993A1 (en) | 2012-02-16 |
| EP2408933A2 (en) | 2012-01-25 |
| EA201171131A1 (ru) | 2012-03-30 |
| CN102575284A (zh) | 2012-07-11 |
| SG174877A1 (en) | 2011-11-28 |
| WO2010105815A3 (en) | 2010-11-25 |
| JP2012520663A (ja) | 2012-09-10 |
| CA2755734A1 (en) | 2010-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011009597A (es) | Deteccion mejorada de la expresion del gen. | |
| MX2010002965A (es) | Deteccion mejorada de la expresion de mage-a. | |
| NZ591416A (en) | Antisense oligonucleotides directed against connective tissue growth factor and uses thereof | |
| NZ588658A (en) | Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor | |
| WO2008078180A3 (en) | Materials and methods for the generation of transcripts comprising modified nucleotides | |
| WO2009108866A3 (en) | Microrna signatures associated with cytogenetics and prognosis in acute myeloid leukemia (aml) and uses thereof | |
| NZ587060A (en) | Rna interference for the treatment of heart failure | |
| NZ723570A (en) | Compositions and methods for quantifying a nucleic acid sequence in a sample | |
| WO2008087040A3 (en) | Methods and nucleic acids for analyses of cell proliferative disorders | |
| WO2009111643A3 (en) | Microrna markers for recurrence of colorectal cancer | |
| NZ599032A (en) | Modulation of huntingtin expression | |
| WO2011005860A3 (en) | 5' phosphate mimics | |
| IL202530A0 (en) | Targeted nucleotide exchange with improved modified oligonucleotides | |
| WO2008087641A3 (en) | H19 silencing nucleic acid agents for treating rheumatoid arthritis | |
| MX2009012482A (es) | Oligonucleotidos de clase a con potencia inmunoestimuladora. | |
| WO2011073629A3 (en) | Cancer diagnosis and treatment | |
| WO2010135836A8 (en) | Novel beta-glucosidase enzymes | |
| WO2011043809A9 (en) | Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling | |
| WO2009074328A3 (en) | Methods and nucleic acids for analyses of lung carcinoma | |
| IN2012DN01979A (https=) | ||
| NZ706930A (en) | Genetic markers for myb28 | |
| MY184632A (en) | A method of identifying parentage in freshwater prawn macrobrachium rosenbergii | |
| EP2383349A3 (en) | Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium using the same | |
| MX348555B (es) | Agente preventivo o terapeutico contra la fibrosis. | |
| EP2660337A3 (en) | Methods and nucleic acids for analyses of cell proliferative disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |